Hepatic metabolism of oxidatively modified apo E-free high-density lipoproteins

Liver

Volumn 18, Issue 4, 1998, Pages 264-271

  DeLamatre, John G ^a,b   Gabaldon, Donna M ^a   Arnold, C Shane ^a   Sarphie, T G ^b   Hornick, Conrad A ^a  

^a Department of Physiology   (United States)

^b LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

Catalase; Endocytosis; Lysosomes; Oxidized high density lipoprotein; Peroxisomes; Phosphatidyl choline; Retroendocytosis

Indexed keywords

ACID PHOSPHATASE; APOLIPOPROTEIN B; DIAMINOBENZIDINE; OXIDIZED LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; ARTICLE; CELL METABOLISM; CONTROLLED STUDY; ELECTRON MICROSCOPY; HEPATOMA CELL; LIPOPROTEIN METABOLISM; LIVER METABOLISM; LYSOSOME; NONHUMAN; PROTEIN DEGRADATION; RAT;

EID: 0031784750     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0676.1998.tb00164.x     Document Type: Article

References (24)

1. MILLER N E. Associations of high density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis. Am Heart J 1987; 113: 589-97.
2. MILLER N E. Current concepts of the role of HDL in reverse cholesterol transport. In MILLER N E, MILLER G J eds. Clinical and metabolic aspects of high density lipoproteins. Amsterdam: Elsevier, 1984; 187-216.
3. JOHNSON W J, MAHLBERG F H, ROTHBLAT G H, PHILLIPS M C. Cholesterol transport between cells and high density lipoproteins. Biochim Biophys Acta 1991; 1085: 273-98.
4. GOLDSTEIN J L, HO Y K, BASU S K, BROWN M S. Binding site on macrophages that dictates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci USA 1979; 76: 333-7.
5. STEINBRECHER U P, PARTHASARATHY S, LEAKE D S, WITZUM J L, STEINBERG D. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation. Proc Natl Acad Sci USA 1984; 81: 3883-7.
6. FOGELMAN A M, SCHECTER J S, HOKOM M, CHILD J S, EDWARDS P A. Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophases. Proc Natl Acad Sci USA 1980, 77: 2214-8.
7. STEINBERG D. Lipoproteins and atherosclerosis: some unanswered questions. Am. Heart J. 1987; 113: 625-32.
8. PARTHASARATHY S, BARNETT J, FONG L G. High-density lipoprotein inhibit the oxidative modification of low-density lipoprotein. Biochim Biophys Acta 1990; 1044: 275-83.
9. BOWRY V W, STANLEY K K, STOCKER R. High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors. Proc Natl Acad Sci USA 1992; 89: 10316-20.
10. DELAMATRE J G, CARTER R M, HORNICK C A. Evidence for extralysosomal hydrolysis of high-density lipoprotein cholesteryl esters in rat hepatoma cells (Fu5AH): a model for delivery of high-density lipoprotein cholesterol. J Cell Physiol 1991; 146: 18-24.
11. DELAMATRE J G, SARPHIE T G, ARCHIBOLD R C, HORNICK C A. Metabolism of apoE-free high density lipoproteins in rat hepatoma cells: evidence for a retroendocytic pathway. J Lipid Res 1990; 31: 191-202.
12. MCFARLANE A S. Efficient trace-labeling of proteins with iodine. Nature 1958; 182: 53-7.
13. NAGANO Y, ARAI H, KITA T. High density lipoprotein loses its effect to stimulate efflux of cholesterol from foam cells after oxidative modification. Proc Natl Acad Sci USA 1991; 88: 6457-61.
14. LEFEVRE M, GOUDEY-LEFEVRE J C, ROHEIM P S. Gradient gel electrophoresis-immunoblot analysis (GGEI): a sensitive method for apolipoprotein profile determinations. J Lipid Res 1987; 28: 1495-507.
15. BLIGH E G, DYER W J. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959; 37: 911-7.
16. LOWRY O H, ROSEBROUGH N J, FARR A L, RANDALL R J. Protein measurement with the folin reagent. J Biol Chem 1951; 193: 265-75.
17. SARPHIE T G. Interactions of IgG and Beta-VLDL with aortic valve endothelium from hypercholesterolemic rabbits. Atherosclerosis 1987; 68: 199-212.
18. MUHLFORDT J A. The preparation of colloidal gold particles using tannic acid as an additional reducing agent. Experientia 1982; 38: 1127-8.
19. HEUSER J. Changes in lysosome shape and distribution correlated with change in cytoplasmic pH. J Cell Biol 1989; 108: 855-63.
20. NOVIKOFF A B, NOVIKOFF P M, DAVIS C, QUINTANA N. Studies on microperoxisomes. II. A cytochemical method for light and electron microscopy. J Histochem Cytochem 1972; 20: 1006-22.
21. NOVIKOFF P M, NOVIKOFF A B, QUINTANA N, DAVIS C. Studies on microperoxisomes. III. Observations on human and rat hepatocytes. J Histochem Cytochem 1973; 21: 540-58.
22. GOLDSTEIN J L, BROWN M S. Binding and degradation of low density lipoproteins by cultured human fibroblasts. J Biol Chem 1974; 249: 5153-62.
23. LALWANI N D, REDDY M K, QURESHI S A, SIRTORI C R, ABIKO Y, REDDY J K. Evaluation of selected hypolipidemic agents for the induction of peroxisomal enzymes and peroxisome proliferation in the rat liver. Human Toxicol 1983; 2: 27-48.
24. CABANA V G, SIEGEL J N, SABESIN S M. Effects of the acute phase response on concentration and density distribution of plasma lipids and apolipoproteins. J Lipid Res 1989; 30: 39-49.